Compare
AbbVie vs McKesson (ABBV vs MCK)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year AbbVie (ABBV) returned +34.4% and McKesson (MCK) +25.6%; so far this year the figures are +27.5% and +29.3%.
AbbVie is the larger company by market value, about 4.2 times the size of McKesson.
On trailing earnings, ABBV trades at 50.1 times and MCK at 27.3 times.
Revenue grew +10.7% at ABBV and +8.2% at MCK over the last year.
ABBV yields 2.38%. MCK yields 0.32%.
Data as of the latest close. Not investment advice.
Relative performance
| ABBV | MCK | |
|---|---|---|
| Price | $291.31 | $1,060.84 |
| 1-day | +1.07% | -1.04% |
| YTD | +27.49% | +29.32% |
| 1 year | +34.39% | +25.65% |
| 3 years | +104.47% | +130.82% |
| Market cap | $514.9B | $122.5B |
| P/E | 50.1 | 27.3 |
| P/S | 7.80 | 0.29 |
| P/B | — | — |
| Revenue growth | +10.70% | +8.20% |
| EPS growth | +340.20% | +21.20% |
| Gross margin % | 73.7 | 3.7 |
| Net margin % | 15.7 | 1.1 |
| ROE % | — | — |
| Debt / equity | — | — |
| FCF yield % | 3.7 | 5.8 |
| Dividend yield % | 2.38 | 0.32 |
| Beta | -0.03 | -0.17 |
| RSI (14) | 59.7 | 70.2 |
| Technical rating |